Shareholders to Vote on Company Dissolution and Liquidation
Summary
Vicarious Surgical Inc. has filed its definitive proxy statement, seeking shareholder approval to dissolve and liquidate the company, with common stockholders unlikely to receive any distributions.
Key Events
-
Shareholder Vote on Dissolution
Shareholders will vote on July 21, 2026, to approve the assignment for the benefit of creditors, followed by a voluntary dissolution and liquidation of the company.
-
Unlikely Shareholder Distributions
The company explicitly states it is unlikely that common stockholders will receive any distributions from the liquidation process due to outstanding liabilities.
-
Cessation of Operations
Upon approval and completion of the dissolution, the company will cease all business activities except those related to winding up and liquidating its affairs.
-
Termination of Public Status
The company intends to terminate its status as a reporting company with the SEC upon completion of the assignment and dissolution, following its prior delisting from the NYSE.
Analysis
This definitive proxy statement formalizes the company's plan to dissolve and liquidate, following previous disclosures of a going concern warning and NYSE delisting. The filing explicitly states that common stockholders are unlikely to receive any distributions, marking the end of the company as an operating entity and a complete loss for equity investors.
At the time of this filing, RBOTW was trading at $0.00 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $1.6M. The 52-week trading range was $0.00 to $0.09. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.